145 related articles for article (PubMed ID: 38139811)
41. Proliferative ability and accumulation of cancer stem cells in oral submucous fibrosis epithelium.
Xie C; Feng H; Zhong L; Shi Y; Wei Z; Hua Y; Ji N; Li J; Tang Z; Chen Q
Oral Dis; 2020 Sep; 26(6):1255-1264. PubMed ID: 32267986
[TBL] [Abstract][Full Text] [Related]
42. miR-10b regulated by Twist maintains myofibroblasts activities in oral submucous fibrosis.
Fang CY; Yu CC; Liao YW; Hsieh PL; Ohiro Y; Chu PM; Huang YC; Yu CH; Tsai LL
J Formos Med Assoc; 2020 Jul; 119(7):1167-1173. PubMed ID: 32265096
[TBL] [Abstract][Full Text] [Related]
43. MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer.
Shiah SG; Hsiao JR; Chang HJ; Hsu YM; Wu GH; Peng HY; Chou ST; Kuo CC; Chang JY
J Biomed Sci; 2020 Apr; 27(1):46. PubMed ID: 32238162
[TBL] [Abstract][Full Text] [Related]
44. DNA hypermethylation of sirtuin 1 (SIRT1) caused by betel quid chewing-a possible predictive biomarker for malignant transformation.
Islam S; Uehara O; Matsuoka H; Kuramitsu Y; Adhikari BR; Hiraki D; Toraya S; Jayawardena A; Saito I; Muthumala M; Nagayasu H; Abiko Y; Chiba I
Clin Epigenetics; 2020 Jan; 12(1):12. PubMed ID: 31931863
[TBL] [Abstract][Full Text] [Related]
45. E3 ligase carboxyl-terminus of Hsp70-interacting protein (CHIP) suppresses fibrotic properties in oral mucosa.
Chen SC; Liu CM; Hsieh PL; Liao YW; Lin YJ; Yu CC; Yu CH
J Formos Med Assoc; 2020 Feb; 119(2):595-600. PubMed ID: 31653576
[TBL] [Abstract][Full Text] [Related]
46. Cytokines secreted by arecoline activate fibroblasts that affect the balance of TH17 and Treg.
Wang L; Gu L; Tang Z
J Oral Pathol Med; 2020 Feb; 49(2):156-163. PubMed ID: 31610043
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1.
Chou ST; Peng HY; Mo KC; Hsu YM; Wu GH; Hsiao JR; Lin SF; Wang HD; Shiah SG
J Exp Clin Cancer Res; 2019 Jun; 38(1):281. PubMed ID: 31253192
[TBL] [Abstract][Full Text] [Related]
48. Arecoline-regulated ataxia telangiectasia mutated expression level in oral cancer progression.
Tu HF; Chen MY; Lai JC; Chen YL; Wong YW; Yang CC; Chen HY; Hsia SM; Shih YH; Shieh TM
Head Neck; 2019 Aug; 41(8):2525-2537. PubMed ID: 30821076
[TBL] [Abstract][Full Text] [Related]
49. Arecoline N-oxide regulates oral squamous cell carcinoma development through NOTCH1 and FAT1 expressions.
Kuo TM; Nithiyanantham S; Lee CP; Hsu HT; Luo SY; Lin YZ; Yeh KT; Ko YC
J Cell Physiol; 2019 Aug; 234(8):13984-13993. PubMed ID: 30624777
[TBL] [Abstract][Full Text] [Related]
50. Slug mediates myofibroblastic differentiation to promote fibrogenesis in buccal mucosa.
Fang CY; Hsia SM; Hsieh PL; Liao YW; Peng CY; Wu CZ; Lin KC; Tsai LL; Yu CC
J Cell Physiol; 2019 May; 234(5):6721-6730. PubMed ID: 30230545
[TBL] [Abstract][Full Text] [Related]
51. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.
Tricco AC; Lillie E; Zarin W; O'Brien KK; Colquhoun H; Levac D; Moher D; Peters MDJ; Horsley T; Weeks L; Hempel S; Akl EA; Chang C; McGowan J; Stewart L; Hartling L; Aldcroft A; Wilson MG; Garritty C; Lewin S; Godfrey CM; Macdonald MT; Langlois EV; Soares-Weiser K; Moriarty J; Clifford T; Tunçalp Ö; Straus SE
Ann Intern Med; 2018 Oct; 169(7):467-473. PubMed ID: 30178033
[TBL] [Abstract][Full Text] [Related]
52. Exposure to nicotine-derived nitrosamine ketone and arecoline synergistically facilitates tumor aggressiveness via overexpression of epidermal growth factor receptor and its downstream signaling in head and neck squamous cell carcinoma.
Yang SH; Lee TY; Ho CA; Yang CY; Huang WY; Lin YC; Nieh S; Lin YS; Chen SF; Lin FH
PLoS One; 2018; 13(8):e0201267. PubMed ID: 30148841
[TBL] [Abstract][Full Text] [Related]
53. miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts.
Lu MY; Yu CC; Chen PY; Hsieh PL; Peng CY; Liao YW; Yu CH; Lin KH
J Formos Med Assoc; 2018 Sep; 117(9):791-797. PubMed ID: 29958727
[TBL] [Abstract][Full Text] [Related]
54. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
Liao YW; Yu CC; Hsieh PL; Chang YC
J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
[TBL] [Abstract][Full Text] [Related]
55. Oral submucous fibrosis: Newer proposed classification with critical updates in pathogenesis and management strategies.
Passi D; Bhanot P; Kacker D; Chahal D; Atri M; Panwar Y
Natl J Maxillofac Surg; 2017; 8(2):89-94. PubMed ID: 29386809
[TBL] [Abstract][Full Text] [Related]
56. Effects of arecoline on proliferation of oral squamous cell carcinoma cells by dysregulating c-Myc and miR-22, directly targeting oncostatin M.
Chuerduangphui J; Ekalaksananan T; Chaiyarit P; Patarapadungkit N; Chotiyano A; Kongyingyoes B; Promthet S; Pientong C
PLoS One; 2018; 13(1):e0192009. PubMed ID: 29385191
[TBL] [Abstract][Full Text] [Related]
57. Arecoline N-Oxide Upregulates Caspase-8 Expression in Oral Hyperplastic Lesions of Mice.
Chang PY; Kuo TM; Chen PK; Lin YZ; Hua CH; Chen YC; Ko YC
J Agric Food Chem; 2017 Nov; 65(47):10197-10205. PubMed ID: 29092399
[TBL] [Abstract][Full Text] [Related]
58. Cracking the Betel Nut: Cholinergic Activity of Areca Alkaloids and Related Compounds.
Horenstein NA; Quadri M; Stokes C; Shoaib M; Papke RL
Nicotine Tob Res; 2019 May; 21(6):805-812. PubMed ID: 29059390
[TBL] [Abstract][Full Text] [Related]
59. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
[TBL] [Abstract][Full Text] [Related]
60. Aberrant SSEA-4 upregulation mediates myofibroblast activity to promote pre-cancerous oral submucous fibrosis.
Yu CC; Yu CH; Chang YC
Sci Rep; 2016 Nov; 6():37004. PubMed ID: 27845370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
